Literature DB >> 8901374

Impact of the global on patient perceivable change in an asthma specific QOL questionnaire.

B L Barber1, N C Santanello, R S Epstein.   

Abstract

One method of defining clinically meaningful changes in quality of life domain scores is 'anchoring', that is, relating changes in domain scores to more easily understood changes on a global question. Although this methodology has been used to assess changes in domain scores in clinical trials, the choice of global question has not undergone much scrutiny. This study examines the impact of two global questions on the definition of clinically meaningful changes in an asthma specific quality of life (ASQOL) questionnaire. We tracked 343 patients with mild to moderate asthma symptoms in a placebo controlled clinical trial. The patients responded to the ASQOL questionnaire, and answered two global questions; one assessing how well their asthma is controlled, and the other assessing the change in their asthma since the start of the study. Changes in each domain of the ASQOL questionnaire were related to each global question. Since each global question led to different definitions of what constituted meaningful change, we concluded that the wording of the global question can affect the definition of meaningful change in the ASQOL domain scores. Thus, when identifying meaningful changes, it is important to state the global question so that the context of the meaningful change is correctly understood.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901374     DOI: 10.1007/bf00435976

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  8 in total

1.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

Authors:  E F Juniper; G H Guyatt; R S Epstein; P J Ferrie; R Jaeschke; T K Hiller
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

2.  Measurement of health status. Ascertaining the minimal clinically important difference.

Authors:  R Jaeschke; J Singer; G H Guyatt
Journal:  Control Clin Trials       Date:  1989-12

3.  Quantification of agreement in psychiatric diagnosis. A new approach.

Authors:  R L Spitzer; J Cohen; J L Fleiss; J Endicott
Journal:  Arch Gen Psychiatry       Date:  1967-07

Review 4.  The significance of treatment effects: the clinical perspective.

Authors:  R A Deyo; D L Patrick
Journal:  Med Care       Date:  1995-04       Impact factor: 2.983

Review 5.  Interpretation of quality of life changes.

Authors:  E Lydick; R S Epstein
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

6.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

7.  Performance of an asthma quality of life questionnaire in an outpatient setting.

Authors:  B H Rowe; A D Oxman
Journal:  Am Rev Respir Dis       Date:  1993-09

8.  Measuring quality of life in asthma.

Authors:  E F Juniper; G H Guyatt; P J Ferrie; L E Griffith
Journal:  Am Rev Respir Dis       Date:  1993-04
  8 in total
  7 in total

1.  The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?

Authors:  R D Hays; J M Woolley
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

2.  Estimating clinically significant differences in quality of life outcomes.

Authors:  Kathleen W Wyrwich; Monika Bullinger; Neil Aaronson; Ron D Hays; Donald L Patrick; Tara Symonds
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

3.  Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample.

Authors:  N K Leidy; C Coughlin
Journal:  Qual Life Res       Date:  1998-02       Impact factor: 4.147

Review 4.  Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease: an expert consensus panel report.

Authors:  Kathleen W Wyrwich; Stephan D Fihn; William M Tierney; Kurt Kroenke; Ajit N Babu; Fredric D Wolinsky
Journal:  J Gen Intern Med       Date:  2003-03       Impact factor: 5.128

5.  Responsiveness of the quality of life in epilepsy inventory (QOLIE-89) in an antiepileptic drug trial.

Authors:  Sehyun Kim; Ron D Hays; Gretchen L Birbeck; Barbara G Vickrey
Journal:  Qual Life Res       Date:  2003-03       Impact factor: 4.147

Review 6.  Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.

Authors:  Jenni Hislop; Temitope E Adewuyi; Luke D Vale; Kirsten Harrild; Cynthia Fraser; Tara Gurung; Douglas G Altman; Andrew H Briggs; Peter Fayers; Craig R Ramsay; John D Norrie; Ian M Harvey; Brian Buckley; Jonathan A Cook
Journal:  PLoS Med       Date:  2014-05-13       Impact factor: 11.069

Review 7.  Patient reports of the outcomes of treatment: a structured review of approaches.

Authors:  Helen Lloyd; Crispin Jenkinson; Monica Hadi; Elizabeth Gibbons; Ray Fitzpatrick
Journal:  Health Qual Life Outcomes       Date:  2014-01-14       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.